Industrial Biotechnology Centre and School of Biosciences, University of Kent, Canterbury, Kent CT2 7NJ, UK.
Biotechnol J. 2018 Oct;13(10):e1800066. doi: 10.1002/biot.201800066. Epub 2018 Jul 5.
Transcriptomics has been extensively applied to the investigation of the CHO cell platform for the production of recombinant biotherapeutic proteins to identify transcripts whose expression is regulated and correlated to (non)desirable CHO cell attributes. However, there have been few attempts to analyze the findings across these studies to identify conserved changes and generic targets for CHO cell platform engineering. Here, the authors have undertaken a meta-analysis of CHO cell transcriptomic data and report on those genes most frequently identified as differentially expressed with regard to cell growth (μ) and productivity (Qp). By aggregating differentially expressed genes from publicly available transcriptomic datasets associated with μ and Qp, using a pathway enrichment analysis and combining it with the concordance of gene expression values, the authors have identified a refined target gene and pathway list while determining the overlap across CHO transcriptomic studies. The authors find that only the cell cycle and lysosome pathways show good concordance. By mapping out the contributing genes the authors have constructed a transcriptomic "fingerprint" of a high-performing cell line. This study provides a starting resource for researchers who want to navigate the complex landscape of CHO transcriptomics and identify targets to undertake cell engineering for improved recombinant protein output.
转录组学已被广泛应用于 CHO 细胞生产重组生物治疗蛋白的研究,以鉴定表达受调控且与(非)理想 CHO 细胞特性相关的转录本。然而,很少有研究试图对这些研究的结果进行分析,以确定 CHO 细胞平台工程的保守变化和通用靶点。在这里,作者对 CHO 细胞转录组数据进行了荟萃分析,并报告了与细胞生长 (μ) 和生产力 (Qp) 相关的差异表达基因。作者通过对与 μ 和 Qp 相关的公开转录组数据集的差异表达基因进行汇总,使用通路富集分析并结合基因表达值的一致性,确定了一个经过精炼的目标基因和通路列表,同时确定了 CHO 转录组研究之间的重叠。作者发现,只有细胞周期和溶酶体途径显示出良好的一致性。通过绘制贡献基因图谱,作者构建了一个高产细胞系的转录组“指纹”。本研究为希望探索 CHO 转录组学复杂领域并确定目标以进行细胞工程以提高重组蛋白产量的研究人员提供了一个起点资源。